{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:15:05Z","timestamp":1756898105219,"version":"3.41.2"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1212\/con.0000000000000248","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T04:34:17Z","timestamp":1449203657000},"page":"1639-1661","source":"Crossref","is-referenced-by-count":4,"title":["Tropical Neuroinfectious Diseases"],"prefix":"10.1212","volume":"21","author":[{"given":"Kiran","family":"Thakur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Thakur K Zunt J. Neurologic parasitic infections in immigrants and travelers. Semin Neurol 2011; 31 (3): 231\u2013244. doi:10.1055\/s-0031-1287651.","DOI":"10.1055\/s-0031-1287651"},{"key":"e_1_3_1_3_2","unstructured":"2. World Health Organization. Neglected tropical diseases. www.who.int\/neglected_diseases\/diseases\/en\/. Accessed October 8 2015."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Berkowitz AL Raibagkar P Pritt BS Mateen FJ. Neurologic manifestations of neglected tropical diseases. J Neurol Sci 2015; 349 (1\u20132): 20\u201332. doi:10.1016\/j.jns.2015.01.001.","DOI":"10.1016\/j.jns.2015.01.001"},{"key":"e_1_3_1_5_2","unstructured":"4. World Health Organization. Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. www.who.int\/neglected_diseases\/2010report\/en\/. Accessed October 8 2015."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Garcia HH Nash TE Del Brutto OH. Clinical symptoms diagnosis and treatment of neurocysticercosis. Lancet Neurol 2014; 13 (12): 1202\u20131215. doi:10.1016\/S1474-4422(14)70094-8.","DOI":"10.1016\/S1474-4422(14)70094-8"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Serpa JA Graviss EA Kass JS White AC Jr. Neurocysticercosis in Houston Texas: an update. Medicine (Baltimore) 2011; 90 (1): 81\u201386. doi:10.1097\/MD.0b013e318206d13e.","DOI":"10.1097\/MD.0b013e318206d13e"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Sorvillo F Wilkins P Shafir S Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 2011; 17 (1): 1\u20136. doi:10.3201\/eid1701.101210.","DOI":"10.3201\/eid1701.101210"},{"key":"e_1_3_1_9_2","unstructured":"8. Centers for Disease Control and Prevention. Laboratory identification of parasitic diseases of public health concern: cysticercosis. www.cdc.gov\/dpdx\/cysticercosis\/. Updated November 29 2013. Accessed October 14 2015."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Carabin H Ndimubanzi PC Budke CM et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 2011; 5 (5): e1152. doi:10.1371\/journal.pntd.0001152.","DOI":"10.1371\/journal.pntd.0001152"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Ndimubanzi PC Carabin H Budke CM et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 2010; 4 (11): e870. doi:10.1371\/journal.pntd.0000870.","DOI":"10.1371\/journal.pntd.0000870"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Del Brutto O Garcia H. Neurocysticercosis. In: Garcia HH Tanowitz HB Del Brutto OH eds. Handbook of clinical neurology volume 114. Amsterdam The Netherlands: Elsevier 2013: 313\u2013325.","DOI":"10.1016\/B978-0-444-53490-3.00025-X"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Garcia HH Del Brutto OH; Cysticercosis Working Group in Peru. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005; 4 (10): 653\u2013661. doi:10.1016\/S1474-4422(05)70194-0.","DOI":"10.1016\/S1474-4422(05)70194-0"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Cantu C Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 1996; 53 (3): 233\u2013239. doi:10.1001\/archneur.1996.00550030039021.","DOI":"10.1001\/archneur.1996.00550030039021"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Callacondo D Garcia HH Gonzales I et al. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology 2012; 78 (18): 1394\u20131400. doi:10.1212\/WNL.0b013e318253d641.","DOI":"10.1212\/WNL.0b013e318253d641"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Del Brutto OH. Diagnostic criteria for neurocysticercosis revisited. Pathog Glob Health 2012; 106 (5): 299\u2013304. doi:10.1179\/2047773212Y.0000000025.","DOI":"10.1179\/2047773212Y.0000000025"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Tsang VC Brand JA Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159 (1): 50\u201359. doi:10.1093\/infdis\/159.1.50.","DOI":"10.1093\/infdis\/159.1.50"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","unstructured":"Rodriguez S Dorny P Tsang VC et al. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis 2009; 199 (9): 1345\u20131352. doi:10.1086\/597757.","DOI":"10.1086\/597757"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"Rodriguez S Wilkins P Dorny P. Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health 2012; 106 (5): 286\u2013298. doi:10.1179\/2047773212Y.0000000048.","DOI":"10.1179\/2047773212Y.0000000048"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","unstructured":"Garcia HH Harrison LJ Parkhouse RM et al. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1998; 92 (4): 411\u2013414. doi:10.1016\/S0035-9203(98)91069-0.","DOI":"10.1016\/S0035-9203(98)91069-0"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Baird RA Wiebe S Zunt JR et al. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013; 80 (15): 1424\u20131429. doi:10.1212\/WNL.0b013e31828c2f3e.","DOI":"10.1212\/WNL.0b013e31828c2f3e"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Gogia S Talukdar B Choudhury V Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized double-blind placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003; 97 (4): 416\u2013421. doi:10.1016\/S0035-9203(03)90075-7.","DOI":"10.1016\/S0035-9203(03)90075-7"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Kalra V Dua T Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003; 143 (1): 111\u2013114. doi:10.1016\/S0022-3476(03)00211-7.","DOI":"10.1016\/S0022-3476(03)00211-7"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Rajshekhar V. Surgical management of neurocysticercosis. Int J Surg 2010; 8 (2): 100\u2013104. doi:10.1016\/j.ijsu.2009.12.006.","DOI":"10.1016\/j.ijsu.2009.12.006"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Garcia HH Pretell EJ Gilman RH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350 (3): 249\u2013258. doi:10.1056\/NEJMoa031294.","DOI":"10.1056\/NEJMoa031294"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Garcia HH Gonzales I Lescano AG et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind randomized controlled trial. Lancet Infect Dis 2014; 14 (8): 687\u2013695. doi:10.1016\/S1473-3099(14)70779-0.","DOI":"10.1016\/S1473-3099(14)70779-0"},{"key":"e_1_3_1_33_2","unstructured":"32. USAID\u2019s Neglected Tropical Diseases Program. Schistosomiasis. www.neglecteddiseases.gov\/target_diseases\/schistosomiasis\/. Last updated June 5 2014. Accessed October 8 2015."},{"key":"e_1_3_1_34_2","unstructured":"33. Centers for Disease Control and Prevention. Parasites\u2013schistosomiasis: epidemiology and risk factors. www.cdc.gov\/parasites\/schistosomiasis\/epi.html. Last reviewed November 12 2012. Accessed October 8 2015."},{"key":"e_1_3_1_35_2","unstructured":"34. Centers for Disease Control and Prevention. Parasites\u2014schistosomiasis: biology. www.cdc.gov\/parasites\/schistosomiasis\/biology.html. Updated November 7 2012. Accessed October 8 2015."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Ferrari TC Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol 2011; 10 (9): 853\u2013854. doi:10.1016\/S1474-4422(11)70170-3.","DOI":"10.1016\/S1474-4422(11)70170-3"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"Wu L Wu M Tian D et al. Clinical and imaging characteristics of cerebral schistosomiasis. Cell Biochem Biophys 2012; 62 (2): 289\u2013295. doi:10.1007\/s12013-011-9294-1.","DOI":"10.1007\/s12013-011-9294-1"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","unstructured":"Kane C Most H. Schistosomiasis of the central nervous system; experiences in World War II and a review of the literature. Arch Neurol Psychiatry 1948; 59 (2): 141\u2013183. doi:10.1001\/archneurpsyc.1948.02300370003001.","DOI":"10.1001\/archneurpsyc.1948.02300370003001"},{"key":"e_1_3_1_39_2","unstructured":"Pittella JEH. Neuroschistosomiasis. In: Misra UD Kalita J Shakir RA eds. Tropical neurology. Georgetown: Landes Bioscience 2003: 300\u2013324."},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Pittella JE. Neuroschistosomiasis. Brain Pathol 1997; 7 (1): 649\u2013662. doi:10.1111\/j.1750-3639.1997.tb01080.x.","DOI":"10.1111\/j.1750-3639.1997.tb01080.x"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Caumes E Vidailhet M. Acute neuroschistosomiasis: a cerebral vasculitis to treat with corticosteroids not praziquantel. J Travel Med 2010; 17 (5): 359. doi:10.1111\/j.1708-8305.2010.00452_1.x.","DOI":"10.1111\/j.1708-8305.2010.00452_1.x"},{"key":"e_1_3_1_43_2","unstructured":"Nazel MW el-Morshedy H Farghaly A et al. Schistosoma mansoni infection and cognitive functions of primary school children in Kafr El Sheikh Egypt. J Egypt Public Health Assoc 1999; 74 (1\u20132): 97\u2013119."},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Jukes MC Nokes CA Alcock KJ .; Partnership for Child Development. Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren. Trop Med Int Health 2002; 7 (2): 104\u2013117.","DOI":"10.1046\/j.1365-3156.2002.00843.x"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","unstructured":"Ferrari TC Moreira PR Cunha AS. Clinical characterization of neuroschistosomiasis due to Schistosoma mansoni and its treatment. Acta Trop 2008; 108 (2\u20133): 89\u201397. doi:10.1016\/j.actatropica.2008.04.007.","DOI":"10.1016\/j.actatropica.2008.04.007"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","unstructured":"Ferrari TC Moreira PR Cunha AS. Spinal cord schistosomiasis: a prospective study of 63 cases emphasizing clinical and therapeutic aspects. J Clin Neurosci 2004; 11 (3): 246\u2013253. doi:10.1016\/j.jocn.2003.05.006.","DOI":"10.1016\/j.jocn.2003.05.006"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","unstructured":"Olson S Rossato R Guazzo E. Spinal schistosomiasis. J Clin Neurosci 2002; 9 (3): 317\u2013320. doi:10.1054\/jocn.2001.0981.","DOI":"10.1054\/jocn.2001.0981"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","unstructured":"Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008; 102 (2): 107\u2013116. doi:10.1016\/j.trstmh.2007.08.004.","DOI":"10.1016\/j.trstmh.2007.08.004"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","unstructured":"Carod-Artal FJ. Neuroschistosomiasis. Expert Rev Anti Infect Ther 2010; 8 (11): 1307\u20131318. doi:10.1586\/eri.10.111.","DOI":"10.1586\/eri.10.111"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","unstructured":"Van Gool T Vetter H Vervoort T et al. Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens. J Clin Microbiol 2002; 40 (9): 3432\u20133437. doi:10.1128\/JCM.40.9.3432-3437.2002.","DOI":"10.1128\/JCM.40.9.3432-3437.2002"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","unstructured":"Zhu H Yu C Xia X et al. Assessing the diagnostic accuracy of immunodiagnostic techniques in the diagnosis of schistosomiasis japonica: a meta-analysis. Parasitol Res 2010; 107 (5): 1067\u20131073. doi:10.1007\/s00436-010-1970-3.","DOI":"10.1007\/s00436-010-1970-3"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","unstructured":"Ropper AR Stemmer-Rachamimov A. Case 21-2001\u2014a 31-year-old man with an apparent seizure and a mass in the right parietal lobe. N Engl J Med 2001; 345 (2): 126\u2013131. doi:10.1056\/NEJM200107123450208.","DOI":"10.1056\/NEJM200107123450208"},{"key":"e_1_3_1_54_2","unstructured":"53. Arguin PM Tan KR. Center for Disease Control malaria report 2014 yellow book. wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-3-infectious-diseases-related-to-travel\/malaria. Updated July 10 2015. Accessed October 8 2015."},{"key":"e_1_3_1_55_2","unstructured":"54. World Health Organization. World malaria report 2013. www.who.int\/malaria\/publications\/world_malaria_report_2013\/en\/. Published December 11 2013. Accessed October 8 2015."},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","unstructured":"Lewallen S Bronzan RN Beare NA et al. Using malarial retinopathy to improve the classification of children with cerebral malaria. Trans R Soc Trop Med Hyg 2008; 102 (11): 1089\u20131094. doi:10.1016\/j.trstmh.2008.06.014.","DOI":"10.1016\/j.trstmh.2008.06.014"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","unstructured":"Taylor TE Fu WJ Car RA et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004; 10 (2): 143\u2013145. doi:10.1038\/nm986.","DOI":"10.1038\/nm986"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","unstructured":"Newton CR Warrell DA. Neurological manifestations of falciparum malaria. Ann Neurol 1998; 43 (6): 695\u2013702. doi:10.1002\/ana.410430603.","DOI":"10.1002\/ana.410430603"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","unstructured":"Crawley J Smith S Kirkham F et al. Seizures and status epilepticus in childhood cerebral malaria. QJM 1996; 89 (8): 591\u2013597. doi:10.1093\/qjmed\/89.8.591.","DOI":"10.1093\/qjmed\/89.8.591"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","unstructured":"Mohanty S Mishra SK Pati SS et al. Complications and mortality patterns due to Plasmodium falciparum malaria in hospitalized adults and children Rourkela Orissa India. Trans R Soc Trop Med Hyg 2003; 97 (1): 69\u201370. doi:10.1016\/S0035-9203(03)90027-7.","DOI":"10.1016\/S0035-9203(03)90027-7"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","unstructured":"Birbeck GL Molyneux ME Kaplan PW et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive pediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010; 9 (12): 1173\u20131181. doi:10.1016\/S1474-4422(10)70270-2.","DOI":"10.1016\/S1474-4422(10)70270-2"},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","unstructured":"Potchen MJ Kampondeni SD Seydel KB et al. Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. AJNR Am J Neuroradiol 2012; 33 (9): 1740\u20131746. doi:10.3174\/ajnr.A3035.","DOI":"10.3174\/ajnr.A3035"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","unstructured":"Maitland K Kiguli S Opoka RO et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364 (26): 2483\u20132495. doi:10.1056\/NEJMoa1101549.","DOI":"10.1056\/NEJMoa1101549"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","unstructured":"Crawley J Waruiru C Mithwani S et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised controlled intervention study. Lancet 2000; 355 (9205): 701\u2013706. doi:10.1016\/S0140-6736(99)07148-2.","DOI":"10.1016\/S0140-6736(99)07148-2"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","unstructured":"Ogutu BR Newton CR Muchohi SN et al. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus. Br J Clin Pharmacol 2003; 56 (1): 112\u2013119. doi:10.1046\/j.1365-2125.2003.01829.x.","DOI":"10.1046\/j.1365-2125.2003.01829.x"},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","unstructured":"Dondorp AM Nosten F Yi P et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361 (5): 455\u2013467. doi:10.1056\/NEJMoa0808859.","DOI":"10.1056\/NEJMoa0808859"},{"key":"e_1_3_1_69_2","doi-asserted-by":"crossref","unstructured":"Phyo AP Nkhoma S Stepniewska K et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012; 379 (9830): 1960\u20131966. doi:10.1016\/S0140-6736(12)60484-X.","DOI":"10.1016\/S0140-6736(12)60484-X"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","unstructured":"Dondorp A1 Nosten F Stepniewska K et al. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomized trial. Lancet 2005; 366 (9847): 717\u2013725. doi:10.1016\/S0140-6736(05)67176-0.","DOI":"10.1016\/S0140-6736(05)67176-0"},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","unstructured":"Dondorp AM Fanello CI Hendriksen IC et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label randomised trial. Lancet 2010; 376 (9753): 1647\u20131657. doi:10.1016\/S0140-6736(10)61924-1.","DOI":"10.1016\/S0140-6736(10)61924-1"},{"key":"e_1_3_1_72_2","doi-asserted-by":"crossref","unstructured":"Hoffman SL Rustama D Punjabi NH et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind placebo-controlled trial. J Infect Dis 1988; 158 (2): 325\u2013331. doi:10.1093\/infdis\/158.2.325.","DOI":"10.1093\/infdis\/158.2.325"},{"key":"e_1_3_1_73_2","doi-asserted-by":"crossref","unstructured":"Namutangula B Ndeezi G Byarugaba JS Tumwine JK. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malar J 2007; 6: 138. doi:10.1186\/1475-2875-6-138.","DOI":"10.1186\/1475-2875-6-138"},{"key":"e_1_3_1_74_2","unstructured":"73. World Health Organization. Global tuberculosis report 2014. www.who.int\/tb\/publications\/global_report\/gtbr14_executive_summary.pdf. Published 2014. Accessed October 8 2015."},{"key":"e_1_3_1_75_2","doi-asserted-by":"crossref","unstructured":"Lozano R Naghavi M Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2095\u20132128. doi:10.1016\/S0140-6736(12)61728-0.","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"e_1_3_1_76_2","doi-asserted-by":"crossref","unstructured":"Wolzak NK Cooke ML Orth H van Toorn R. The changing profile of pediatric meningitis at a referral centre in Cape Town South Africa. J Trop Pediatr 2012; 58 (6): 491\u2013495. doi:10.1093\/tropej\/fms031.","DOI":"10.1093\/tropej\/fms031"},{"key":"e_1_3_1_77_2","doi-asserted-by":"crossref","unstructured":"Donald PR Schaaf HS Schoeman JF. Tuberculous meningitis and military tuberculosis: the Rich focus revisited. J Infect 2005; 50 (3): 193\u2013195. doi:10.1016\/j.jinf.2004.02.010.","DOI":"10.1016\/j.jinf.2004.02.010"},{"key":"e_1_3_1_78_2","doi-asserted-by":"crossref","unstructured":"Rock RB Olin M Baker CA et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21 (2): 243\u2013261. doi:10.1128\/CMR.00042-07.","DOI":"10.1128\/CMR.00042-07"},{"key":"e_1_3_1_79_2","doi-asserted-by":"crossref","unstructured":"van Toorn R Springer P Laubscher JA Schoeman JF. Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis. Int J Tuberc Lung Dis 2012; 16 (5): 628\u2013632. doi:10.5588\/ijtld.11.0648.","DOI":"10.5588\/ijtld.11.0648"},{"key":"e_1_3_1_80_2","doi-asserted-by":"crossref","unstructured":"El Sahly HM Teeter LD Pan X et al. Mortality associated with central nervous system tuberculosis. J Infect 2007; 55 (6): 502\u2013509. doi:10.1016\/j.jinf.2007.08.008.","DOI":"10.1016\/j.jinf.2007.08.008"},{"key":"e_1_3_1_81_2","doi-asserted-by":"crossref","unstructured":"Chanet V Baud O Deffond D et al. Pseudotumor presentation of intracerebral tuberculomas. South Med J 2005; 98 (4): 489\u2013491. doi:10.1097\/01.SMJ.0000152544.47644.25.","DOI":"10.1097\/01.SMJ.0000152544.47644.25"},{"key":"e_1_3_1_82_2","doi-asserted-by":"crossref","unstructured":"Vidal JE Cimerman S da Silva PR et al. Tuberculous brain abscess in a patient with AIDS: case report and literature review. Rev Inst Med Trop Sao Paulo 2003; 45 (2): 111\u2013114. doi:10.1590\/S0036-46652003000200013.","DOI":"10.1590\/S0036-46652003000200013"},{"key":"e_1_3_1_84_2","doi-asserted-by":"crossref","unstructured":"Vidal JE Oliveira AC Dauar RF. Cerebral tuberculomas or tuberculous brain abscess: the dilemma continues. Clin Infect Dis 2005; 40 (7): 1072\u20131073. doi:10.1086\/428673.","DOI":"10.1086\/428673"},{"key":"e_1_3_1_85_2","doi-asserted-by":"crossref","unstructured":"Fuentes Ferrer M Guti\u00e9rrez Torres L Ayala Ram\u00edrez O et al. Tuberculosis of the spine. A systematic review of case series. Int Orthop 2012; 36 (2): 221\u2013231. doi:10.1007\/s00264-011-1414-4.","DOI":"10.1007\/s00264-011-1414-4"},{"key":"e_1_3_1_86_2","doi-asserted-by":"crossref","unstructured":"Thwaites FE Chau TT Stepniewska K et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360 (9342): 1287\u20131292. doi:10.1016\/S0140-6736(02)11318-3.","DOI":"10.1016\/S0140-6736(02)11318-3"},{"key":"e_1_3_1_87_2","doi-asserted-by":"crossref","unstructured":"Gupta BK Bharat A Debapriya B Baruah H. Adenosine deaminase levels in CSF of tuberculous meningitis patients. J Clin Med Res 2010; 2 (5): 220\u2013224. doi:10.4021\/jocmr429w.","DOI":"10.4021\/jocmr429w"},{"key":"e_1_3_1_90_2","unstructured":"World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children: Policy update. Geneva Switzerland: World Health Organization 2013."},{"key":"e_1_3_1_91_2","unstructured":"90. World Health Organization. Treatment of tuberculosis guidelines fourth edition. apps.who.int\/iris\/bitstream\/10665\/44165\/1\/9789241547833_eng.pdf?ua=1&ua=1. Published 2010. Accessed October 8 2015."},{"key":"e_1_3_1_92_2","doi-asserted-by":"crossref","unstructured":"Ruslami R Ganiem AR Dian S et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label randomised controlled phase 2 trial. Lancet Infect Dis 2013; 13 (1): 27\u201335. doi:10.1016\/S1473-3099(12)70264-5.","DOI":"10.1016\/S1473-3099(12)70264-5"},{"key":"e_1_3_1_93_2","doi-asserted-by":"crossref","unstructured":"Thwaites GE Nguyen DB Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351 (17): 1741\u20131751. doi:10.1056\/NEJMoa040573.","DOI":"10.1056\/NEJMoa040573"},{"key":"e_1_3_1_94_2","doi-asserted-by":"crossref","unstructured":"Schoeman JF Van Zyl LE Laubscher JA et al. Effect of corticosteroids on intracranial pressure computed tomographic findings and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997; 99 (2): 226\u2013231. doi:10.1542\/peds.99.2.226.","DOI":"10.1542\/peds.99.2.226"},{"key":"e_1_3_1_95_2","doi-asserted-by":"crossref","unstructured":"Tobin DM Roca FJ Oh SF et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012; 148 (3): 434\u2013446. doi:10.1016\/j.cell.2011.12.023.","DOI":"10.1016\/j.cell.2011.12.023"},{"key":"e_1_3_1_96_2","doi-asserted-by":"crossref","unstructured":"Yang J Chen J Yue J et al. Relationship between human LTA4H polymorphisms and extra-pulmonary tuberculosis in an ethnic Han Chinese population in Eastern China. Tuberculosis (Edinb) 2014; 94 (6): 657\u2013663. doi:10.1016\/j.tube.2014.08.014.","DOI":"10.1016\/j.tube.2014.08.014"},{"key":"e_1_3_1_97_2","unstructured":"96. World Health Organization. Dengue guidelines for diagnosis treatment prevention and control. whqlibdoc.who.int\/publications\/2009\/9789241547871_eng.pdf. Published 2009. Accessed October 8 2015."},{"key":"e_1_3_1_98_2","doi-asserted-by":"crossref","unstructured":"Sahu R Verma R Jain A et al. Neurologic complications in dengue virus infection: a prospective cohort study. Neurology 2014; 83 (18): 1601\u20131609. doi:10.1212\/WNL.0000000000000935.","DOI":"10.1212\/WNL.0000000000000935"},{"key":"e_1_3_1_99_2","doi-asserted-by":"crossref","unstructured":"Cologna R Armstrong PM Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol 2005; 79 (2): 853\u2013859. doi:10.1128\/JVI.79.2.853-859.2005.","DOI":"10.1128\/JVI.79.2.853-859.2005"},{"key":"e_1_3_1_100_2","doi-asserted-by":"crossref","unstructured":"Solomon T Dung NM Vaughn DW et al. Neurological manifestations of dengue infection. Lancet 2000; 355 (9209): 1053\u20131059. doi:10.1016\/S0140-6736(00)02036-5.","DOI":"10.1016\/S0140-6736(00)02036-5"},{"key":"e_1_3_1_102_2","doi-asserted-by":"crossref","unstructured":"Wright WF Pritt BS. Update: the diagnosis and management of dengue virus infection in North America. Diagn Microbiol Infect Dis 2012; 73 (3): 215\u2013220. doi:10.1016\/j.diagmicrobio.2012.03.021.","DOI":"10.1016\/j.diagmicrobio.2012.03.021"},{"key":"e_1_3_1_103_2","doi-asserted-by":"crossref","unstructured":"Singh K Lale A Eong Ooi E et al. A prospective clinical study on the use of reverse transcription-polymerase chain reaction for the early diagnosis of dengue fever. J Mole Diagn 2006; 8 (5): 613\u2013616. doi:10.2353\/jmoldx.2006.060019.","DOI":"10.2353\/jmoldx.2006.060019"},{"key":"e_1_3_1_104_2","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo F Nogueira R Ara\u00fajo Mde S et al. Dengue in patients with central nervous system manifestations Brazil. Emerg Infect Dis 2012; 18 (4): 677\u2013679. doi:10.3201\/eid1804.111552.","DOI":"10.3201\/eid1804.111552"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:10:29Z","timestamp":1752156629000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1212\/CON.0000000000000248"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000248","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"type":"print","value":"1080-2371"},{"type":"electronic","value":"1538-6899"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}